# Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction

> **NCT04663932** · NA · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 240 (estimated)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia
- Acute Coronary Syndrome
- Heart Diseases
- Syndrome Heart Disease
- Cardiovascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Coronary Disease
- Vascular Diseases

## Interventions

- **PROCEDURE:** immediate stenting group(one-step strategy)
- **PROCEDURE:** deferred stenting group (two-step strategy)

## Key facts

- **NCT ID:** NCT04663932
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-22
- **Primary completion:** 2022-03
- **Final completion:** 2023-03
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04663932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04663932, "Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04663932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*